Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2025-12-24 @ 11:34 PM
NCT ID:
NCT06827756
Eligibility Criteria:
Inclusion Criteria:
Success Criteria: A ≥50% reduction in CRP within 3 months is considered a positive response.
* Ascitic patients diagnosed with Spontaneous Bacterial Peritonitis (SBP) by paracentesis.
* Ascitic fluid polymorphonuclear (PMN) cell count \> 250/mm³.
* Age 50 years to 80 years.
* Willing to provide informed consent.
Exclusion Criteria:
* Pregnant or breastfeeding females.
* History of allergic reactions to Norfloxacin, Nitazoxanide, or Colistin.
* Patients with recurrent spontaneous peritonitis.
* Presence of gastrointestinal hemorrhage.
* Renal failure (Creatinine \> 2 mg/dL or on dialysis).
* Presence of severe infection-related sequelae (e.g., persistent fever, abdominal discomfort, sepsis).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT06827756
Study Brief:
Protocol Section:
NCT06827756